Recombinant multi-species ZMYND8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZMYND8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a receptor for activated C-kinase (RACK) protein. The encoded protein has been shown to bind in vitro to activated protein kinase C beta I. In addition, this protein is a cutaneous T-cell lymphoma-associated antigen. Finally, the protein contains a bromodomain and two zinc fingers, and is thought to be a transcriptional regulator. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1110013E22Rik,2010005I16Rik,3632413B07Rik,Cutaneous T-cell lymphoma-associated antigen se14-3 (CTCL-associated antigen se14-3),MYND-type zinc finger-containing chromatin reader ZMYND8,PRKCBP1,PRO2893,Prkcbp1,Protein kinase C-binding protein 1,RACK7,Rack7,Transcription coregulator ZMYND8,ZMYND8,Zinc finger MYND domain-containing protein 8,Zmynd8,spikar

Target products collectionGo to ZMYND8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6946-Ag-1/ GM-Tg-hg-IP6946-Ag-2 Human ZMYND8 protein Human
GM-Tg-rg-IP6946-Ag-1/ GM-Tg-rg-IP6946-Ag-2 Rat ZMYND8 protein Rat
GM-Tg-mg-IP6946-Ag-1/ GM-Tg-mg-IP6946-Ag-2 Mouse ZMYND8 protein Mouse
GM-Tg-cynog-IP6946-Ag-1/ GM-Tg-cynog-IP6946-Ag-2 Cynomolgus/Rhesus macaque ZMYND8 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6946-Ag-1/ GM-Tg-felg-IP6946-Ag-2 Feline ZMYND8 protein Feline
GM-Tg-cang-IP6946-Ag-1/ GM-Tg-cang-IP6946-Ag-2 Canine ZMYND8 protein Canine
GM-Tg-bovg-IP6946-Ag-1/ GM-Tg-bovg-IP6946-Ag-2 Bovine ZMYND8 protein Bovine
GM-Tg-equg-IP6946-Ag-1/ GM-Tg-equg-IP6946-Ag-2 Equine ZMYND8 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6946-Ag-1/ GM-Tg-hg-IP6946-Ag-2; GM-Tg-rg-IP6946-Ag-1/ GM-Tg-rg-IP6946-Ag-2;
GM-Tg-mg-IP6946-Ag-1/ GM-Tg-mg-IP6946-Ag-2; GM-Tg-cynog-IP6946-Ag-1/ GM-Tg-cynog-IP6946-Ag-2;
GM-Tg-felg-IP6946-Ag-1/ GM-Tg-felg-IP6946-Ag-2; GM-Tg-cang-IP6946-Ag-1/ GM-Tg-cang-IP6946-Ag-2;
GM-Tg-bovg-IP6946-Ag-1/ GM-Tg-bovg-IP6946-Ag-2; GM-Tg-equg-IP6946-Ag-1/ GM-Tg-equg-IP6946-Ag-2
Products Name ZMYND8 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZMYND8
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZMYND8 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.